Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Lappe

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Circulation Research|April 1, 1985
Failure of atriopeptin II to cause arterial vasodilation in the conscious ratR W Lappe, J F Smits, J A Todt, et al.
Clinical and Experimental Pharmacology & Physiology|February 1, 1987
Hypotensive response to atrial natriuretic factor in conscious renal hypertensive beaglesK C Lee, J A Rodzinski, F J Bex, et al.
The American Journal of Physiology|October 1, 1985
Selective efferent chemical sympathectomy of rat kidneysL M LeNoble, R W Lappe, M J Brody, et al.
American Journal of Hypertension|April 1, 1990
Infusion of recombinant human prorenin into rhesus monkeys. Effects on hemodynamics, renin-angiotensin-aldosterone axis and plasma testosteroneT Lenz, J E Sealey, R W Lappe, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Pharmacological evidence for rapid destruction of efferent renal nerves in rats by intrarenal infusion of 6-hydroxydopamineJ L le Noble, B J Janssen, R W Lappe, et al.
Journal of Neurosurgery|November 1, 1996
Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhageH H Caner, A L Kwan, A Arthur, et al.
Journal of Neurosurgery|August 1, 1997
Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhageA L Kwan, M Bavbek, A Y Jeng, et al.
Biochemical and Biophysical Research Communications|October 3, 1996
In vitro and in vivo evaluation of an endothelin inhibitor reveals novel K+ channel opening activityR L Webb, S Hu, M A Sills, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11R E Chatelain, R D Ghai, A J Trapani, et al.
Biochemistry and Molecular Biology International|December 1, 1993
Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1A J Trapani, J L Balwierczak, R W Lappe, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Circulation Research|April 1, 1985
Failure of atriopeptin II to cause arterial vasodilation in the conscious ratR W Lappe, J F Smits, J A Todt, et al.
Clinical and Experimental Pharmacology & Physiology|February 1, 1987
Hypotensive response to atrial natriuretic factor in conscious renal hypertensive beaglesK C Lee, J A Rodzinski, F J Bex, et al.
The American Journal of Physiology|October 1, 1985
Selective efferent chemical sympathectomy of rat kidneysL M LeNoble, R W Lappe, M J Brody, et al.
American Journal of Hypertension|April 1, 1990
Infusion of recombinant human prorenin into rhesus monkeys. Effects on hemodynamics, renin-angiotensin-aldosterone axis and plasma testosteroneT Lenz, J E Sealey, R W Lappe, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Pharmacological evidence for rapid destruction of efferent renal nerves in rats by intrarenal infusion of 6-hydroxydopamineJ L le Noble, B J Janssen, R W Lappe, et al.
Journal of Neurosurgery|November 1, 1996
Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhageH H Caner, A L Kwan, A Arthur, et al.
Journal of Neurosurgery|August 1, 1997
Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhageA L Kwan, M Bavbek, A Y Jeng, et al.
Biochemical and Biophysical Research Communications|October 3, 1996
In vitro and in vivo evaluation of an endothelin inhibitor reveals novel K+ channel opening activityR L Webb, S Hu, M A Sills, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11R E Chatelain, R D Ghai, A J Trapani, et al.
Biochemistry and Molecular Biology International|December 1, 1993
Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1A J Trapani, J L Balwierczak, R W Lappe, et al.
Pageof 5